Loading...
Selective inhibition of prostacyclin synthase activity by rofecoxib
The development of cyclooxygenase-2 (COX-2) selective inhibitors prompted studies aimed at treating chronic inflammatory diseases and cancer by using this new generation of drugs.Yet, several recent reports pointed out that long-term treatment of patients with COX-2 selective inhibitors (especially...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Blackwell Publishing Ltd
2007
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3822831/ https://ncbi.nlm.nih.gov/pubmed/17488481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1582-4934.2007.00021.x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|